Laboratory Freezers Market
完整報告名稱與涵蓋範圍
Laboratory Freezers Market by Modality (Cryopreservation; Freezer: ULTF, Plasma, Enzyme; Refrigerator: Blood Bank, Pharmacy, Chromatography), Application (Genetic, Vaccine, Biological Sample), End User (Hospital, Pharma, Cell Bank)-Global Forecast to 2031
報告摘要
The global laboratory freezers market is projected to reach USD 5.11 billion by 2031 from USD 4.32 billion in 2026, at a CAGR of 3.5% from 2026 to 2031.
The laboratory freezers market is primarily driven by the increasing need for reliable, temperature-controlled storage of vaccines, biological samples, reagents, blood components, cell lines, tissues, and other temperature-sensitive materials. The rapid expansion of pharmaceutical and biotechnology research, vaccine development, clinical diagnostics, biobanking, genomics, and cell and gene therapy is accelerating the adoption of advanced laboratory freezers across research institutes, hospitals, diagnostic laboratories, pharmaceutical companies, and biobanks. In addition, stringent regulatory and quality requirements for maintaining sample integrity and cold-chain compliance are encouraging end users to adopt freezers equipped with precise temperature control, continuous monitoring, automated data logging, remote alarms, and backup systems. Furthermore, increasing investments in healthcare and life-science infrastructure, the expansion of biorepositories, and growing demand for ultra-low-temperature storage are supporting market growth. Manufacturers are also introducing energy-efficient compressors, environmentally sustainable refrigerants, improved insulation, automated inventory management, and IoT-enabled monitoring systems to reduce operating costs, minimize sample-loss risks, and enhance laboratory workflow efficiency, thereby driving sustained growth of the laboratory freezers market.
“By product, refrigerators accounted for the largest share of the laboratory freezers market in 2025.”
By product, the laboratory freezers market is segmented into freezers, refrigerators, and cryopreservation systems. Refrigerators account for the largest market share due to their widespread use for the routine storage of vaccines, reagents, culture media, pharmaceutical products, blood samples, and other temperature-sensitive materials at controlled temperatures, typically between 2°C and 8°C. Their extensive installation across hospitals, diagnostic laboratories, blood banks, pharmacies, research institutes, and pharmaceutical and biotechnology companies generates strong and recurring demand. Compared with ultra-low-temperature freezers and cryopreservation systems, laboratory refrigerators offer lower acquisition and operating costs, simpler maintenance, and broader applicability in everyday laboratory workflows. Furthermore, expanding diagnostic testing, vaccine programs, clinical research, and pharmaceutical production—along with stringent requirements for temperature stability, continuous monitoring, automated data logging, and regulatory compliance are supporting the segment’s leading position. Growing adoption of energy-efficient, environmentally sustainable, and IoT-enabled refrigerators with remote alarms and backup controls is expected to further drive segment growth.
“By application, the pharmaceutical & vaccine storage segment accounted for the largest share of the laboratory freezers market.”
By application, the laboratory freezers market is segmented into environmental testing, genetic material storage, pharmaceutical & vaccine storage, biological samples & inventory management, and other applications. The pharmaceutical & vaccine storage segment accounted for the largest market share owing to the substantial volume of temperature-sensitive vaccines, biologics, drugs, active pharmaceutical ingredients, reagents, and clinical-trial materials requiring controlled storage. The expansion of vaccine manufacturing and immunization programs, increasing production of biologics and specialty medicines, and growth in pharmaceutical research and clinical trials are creating strong demand for laboratory refrigerators and freezers. Furthermore, stringent regulatory requirements for temperature stability, continuous monitoring, data logging, alarm systems, backup power, and cold-chain compliance encourage pharmaceutical manufacturers, hospitals, pharmacies, research laboratories, and distribution centers to invest in reliable storage equipment. The recurring need to store pharmaceutical products across research, production, quality-control, and distribution workflows further reinforces the segment’s leading market position.
By end user, pharmaceutical & biotechnology companies accounted for the largest share in the forecast period.
By end user, the laboratory freezers market is segmented into hospitals, clinical & pathology laboratories, pharmaceutical & biotechnology companies, academic & research institutes, pharmacies & physicians’ offices, and cell & tissue banks. Pharmaceutical & biotechnology companies accounted for the largest market share due to their extensive requirement for controlled-temperature storage across drug discovery, vaccine development, biologics manufacturing, clinical trials, quality control, and commercial production. These companies store substantial volumes of temperature-sensitive materials, including vaccines, biologics, cell lines, genetic material, reagents, active pharmaceutical ingredients, reference standards, and clinical-trial samples. Rising investment in biopharmaceutical R&D, expanding biologics and biosimilar pipelines, and the development of cell and gene therapies are further increasing demand for refrigerators, ultra-low-temperature freezers, and cryopreservation systems. Moreover, stringent regulatory requirements for sample integrity, temperature monitoring, data logging, alarm management, backup systems, and storage validation support the segment’s leading market position.
“The Asia Pacific market is projected to show the highest growth rate in the laboratory freezers market.”
The laboratory freezers market spans five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Asia Pacific is projected to register the highest growth rate, driven by the rapid expansion of pharmaceutical and biotechnology manufacturing, vaccine production, clinical research, diagnostic testing, and biobanking activities. Increasing healthcare expenditure, government investments in life-science infrastructure, and the establishment of new research laboratories, hospitals, and cold-chain facilities are strengthening demand for laboratory refrigerators, ultra-low-temperature freezers, and cryopreservation systems. The region is also benefiting from the growing production of biologics, biosimilars, and cell and gene therapies, particularly in China, India, Japan, and South Korea. Furthermore, increasing awareness of sample integrity, stricter temperature-control requirements, and rising adoption of energy-efficient and digitally connected storage systems are expected to accelerate regional market growth.
A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1 (45%), Tier 2 (35%), and Tier 3 (20%)
• By Designation: Directors (50%), Managers (30%), and Others (20%)
• By Region: North America (37%), Europe (25%), Asia Pacific (30%), Latin America (5%), and the Middle East & Africa (3%)
The major players in the laboratory freezers market include Thermo Fisher Scientific (US), Haier Biomedical (China), PHC Holdings (Japan), Eppendorf AG (Germany), and Avantor (US), among others
Research Coverage
The research report examines the laboratory freezers market by product, application, end user, and region. This research covers factors driving market expansion, analyzes prospects and parameters faced by industries today, and provides specifics on the competitive landscape, considering market leaders and small and medium enterprises. This research also estimates the revenue of different market segments by considering five regions and micromarket analysis
Reasons to Buy the Report
The report will provide market leaders and new entrants with valuable information regarding the revenue estimates for the overall laboratory freezers market and its subsegments. It will help stakeholders understand the competitive landscape, allowing them to position their businesses more effectively and develop appropriate go-to-market strategies. Additionally, the report offers insights into the market dynamics, including key drivers, restraints, challenges, and opportunities.
This report provides insightful data on the following pointers:
• Market Penetration: In-depth coverage of product portfolios offered by the top players in the laboratory freezers market
• Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and product & service launches in the laboratory freezers market
• Market Development: Insightful data on profitable developing areas
• Market Diversification: Details about recent developments and advancements in the laboratory freezers market
• Competitive Assessment: Extensive assessment of the products, growth tactics, revenue projections, and market categories of the top competitors
授權報價
| Single User Licence | $4,950 USD |
| Multi User Licence | $6,650 USD |
| Corporate User Licence | $8,150 USD |
| Global User Licence | $10,000 USD |
目錄 Table of Contents
1 INTRODUCTION 23
1.1 STUDY OBJECTIVES 23
1.2 MARKET DEFINITION 23
1.3 MARKET SCOPE 24
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 24
1.3.2 INCLUSIONS AND EXCLUSIONS 25
1.3.3 YEARS CONSIDERED 25
1.4 CURRENCY CONSIDERED 26
1.5 STAKEHOLDERS 26
1.6 SUMMARY OF CHANGES 26
2 EXECUTIVE SUMMARY 27
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 27
2.2 DISRUPTIVE TRENDS IN LABORATORY FREEZERS MARKET 29
2.3 HIGH GROWTH SEGMENTS 30
2.4 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 31
3 PREMIUM INSIGHTS 32
3.1 LABORATORY FREEZERS MARKET OVERVIEW 32
3.2 NORTH AMERICA: LABORATORY FREEZERS MARKET, BY COUNTRY AND PRODUCT, 2025 33
3.3 GEOGRAPHIC SNAPSHOT OF LABORATORY FREEZERS MARKET 34
4 MARKET OVERVIEW 35
4.1 INTRODUCTION 35
4.2 MARKET DYNAMICS 36
4.2.1 DRIVERS 36
4.2.1.1 Expanding life science research and temperature-sensitive
biologics storage 36
4.2.1.2 Expanding vaccine and biopharmaceutical production drives demand for validated frozen-storage infrastructure 37
4.2.2 RESTRAINTS 37
4.2.2.1 High capital and lifecycle costs of advanced freezers 37
4.2.2.2 Tightening refrigerant regulations that increase compliance costs 37
4.2.3 OPPORTUNITIES 38
4.2.3.1 Transition to natural-refrigerant and HFC-free cooling technologies 38
4.2.3.2 Growing clinical-trial activity to expand decentralized sample-storage requirements 39
4.2.4 CHALLENGES 39
4.2.4.1 Maintaining temperature uniformity and sample integrity 39
4.2.4.2 Stringent validation and documentation requirements 40
5 INDUSTRY TRENDS 41
5.1 PORTER’S FIVE FORCES ANALYSIS 41
5.1.1 BARGAINING POWER OF BUYERS 42
5.1.2 BARGAINING POWER OF SUPPLIERS 42
5.1.3 THREAT OF NEW ENTRANTS 42
5.1.4 THREAT OF SUBSTITUTES 42
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 42
5.2 MACROECONOMIC INDICATORS 42
5.2.1 GDP TRENDS AND FORECAST 43
5.2.2 TRENDS IN GLOBAL LABORATORY FREEZERS INDUSTRY 44
5.3 SUPPLY CHAIN ANALYSIS 44
5.3.1 PROMINENT COMPANIES 45
5.3.2 SMALL AND MEDIUM-SIZED ENTERPRISES 45
5.3.3 END USERS 45
5.4 VALUE CHAIN ANALYSIS 45
5.4.1 RESEARCH & DEVELOPMENT 46
5.4.2 RAW MATERIAL PROCUREMENT & PRODUCT DEVELOPMENT 46
5.4.3 MARKETING, SALES, AND DISTRIBUTION 47
5.5 ECOSYSTEM ANALYSIS 47
5.6 PRICING ANALYSIS 48
5.6.1 AVERAGE SELLING PRICE OF LABORATORY FREEZERS, BY KEY PLAYER, 2025 48
5.6.2 AVERAGE SELLING PRICE OF PRODUCT, BY KEY PLAYER, 2023–2025 (USD) 48
5.6.3 AVERAGE SELLING PRICE TREND, BY REGION, 2025 49
5.7 TRADE ANALYSIS 51
5.7.1 IMPORT DATA FOR HS CODE 841840 51
5.7.2 IMPORT DATA FOR FREEZERS OF THE UPRIGHT TYPE, OF A CAPACITY
<= 900 L (HS CODE 841840) 52
5.7.3 EXPORT DATA FOR FREEZERS OF THE UPRIGHT TYPE, OF A CAPACITY
<= 900 L (HS CODE 841840) 52
5.8 KEY CONFERENCES & EVENTS, 2026–2027 53
5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 54
5.9.1 DIGITAL MONITORING, SUSTAINABILITY, AND EXPANDING APPLICATIONS TRANSFORM MARKET 54
5.10 INVESTMENT & FUNDING SCENARIO 55
5.11 CASE STUDY ANALYSIS 57
5.11.1 CASE STUDY 57
5.12 IMPACT OF 2025 US TARIFF ON LABORATORY FREEZERS MARKET 58
5.12.1 INTRODUCTION 58
5.12.2 KEY TARIFF RATES 58
5.12.3 KEY TARIFF RATES 58
5.12.4 PRICE IMPACT ANALYSIS 59
5.12.5 IMPACT ON COUNTRY/REGION 59
5.12.5.1 US 59
5.12.5.2 Europe 59
5.12.5.3 Asia Pacific 59
5.12.6 IMPACT ON END USERS 60
6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL,
AND AI ADOPTION 61
6.1 KEY EMERGING TECHNOLOGIES 61
6.1.1 NATURAL/ECO-FRIENDLY REFRIGERANTS 61
6.1.2 SMART/IOT-ENABLED FREEZERS 61
6.2 COMPLEMENTARY TECHNOLOGIES 61
6.2.1 TEMPERATURE-CONTROLLED TRANSPORT SYSTEMS 61
6.2.2 BUILDING-MANAGEMENT-SYSTEM INTEGRATION 61
6.2.3 ROBOTIC AND AUTOMATED SAMPLE-STORAGE SYSTEMS 61
6.3 PATENT ANALYSIS 62
6.4 IMPACT OF AI/GEN AI ON LABORATORY FREEZERS MARKET 63
6.4.1 TOP USE CASES AND MARKET POTENTIAL 64
6.4.2 BEST PRACTICES IN LABORATORY FREEZERS 65
6.4.3 CASE STUDIES OF AI IMPLEMENTATION IN LABORATORY FREEZERS MARKET 65
6.4.4 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS 66
6.4.5 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN LABORATORY FREEZERS MARKET 66
6.5 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 67
7 REGULATORY LANDSCAPE 68
7.1 REGULATORY TRENDS 68
7.1.1 NORTH AMERICA 68
7.1.1.1 US 68
7.1.1.2 Canada 69
7.1.2 EUROPE 70
7.1.3 ASIA PACIFIC 71
7.1.3.1 Japan 71
7.1.3.2 China 71
7.1.3.3 India 73
7.2 KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
7.2.1 NORTH AMERICA 74
7.2.2 EUROPE 74
7.2.3 ASIA PACIFIC 75
7.2.4 LATIN AMERICA 76
7.2.5 MIDDLE EAST & AFRICA 76
7.3 INDUSTRY STANDARDS 77
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 78
8.1 DECISION-MAKING PROCESS 78
8.2 KEY STAKEHOLDERS & BUYING CRITERIA 78
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 79
8.2.2 KEY BUYING CRITERIA 80
8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 80
8.4 UNMET NEEDS OF VARIOUS END USERS 81
9 LABORATORY FREEZERS MARKET, BY PRODUCT 83
9.1 INTRODUCTION 84
9.2 FREEZERS 84
9.2.1 ULTRA-LOW-TEMPERATURE FREEZERS 85
9.2.1.1 Expanding biobanking and cell & gene therapy pipelines drive demand 85
9.2.2 GENERAL-PURPOSE FREEZERS 86
9.2.2.1 Increased clinical and diagnostic test volume to drive market growth 86
9.2.3 PLASMA FREEZERS 87
9.2.3.1 Rising blood component demand and trauma care needs sustain segment growth 87
9.2.4 ENZYME FREEZERS 88
9.2.4.1 Expansion of biotechnology research and enzyme-based diagnostics to drive demand 88
9.2.5 EXPLOSION-PROOF FREEZERS 88
9.2.5.1 Tightening laboratory safety codes accelerate adoption of hazardous-location freezer design 88
9.2.6 FLAMMABLE MATERIAL FREEZERS 89
9.2.6.1 Expanding chemical inventories in research and pharma labs boost demand for dedicated flammable storage 89
9.3 REFRIGERATORS 90
9.3.1 BLOOD BANK REFRIGERATORS 91
9.3.1.1 Growing blood donation networks and trauma caseloads fuel demand 91
9.3.2 CHROMATOGRAPHY REFRIGERATORS 91
9.3.2.1 Precision temperature control for analytical workflows expand segment 91
9.3.3 EXPLOSION-PROOF REFRIGERATORS 92
9.3.3.1 Hazardous-location certification needs enhance demand in R&D labs 92
9.3.4 FLAMMABLE MATERIAL REFRIGERATORS 93
9.3.4.1 Stricter chemical safety compliance drives lab upgrades 93
9.3.5 LABORATORY REFRIGERATORS 93
9.3.5.1 Energy-efficient lab refrigerator to grow market 93
9.3.6 PHARMACY REFRIGERATORS 94
9.3.6.1 Expansion of pharmacy-based vaccination services drives purpose-built cold storage demand 94
9.4 CRYOPRESERVATION SYSTEMS 95
9.4.1 NEED FOR APPROPRIATE CRYOPRESERVATION STORAGE SYSTEMS TO ENSURE SAMPLE INTEGRITY BOOSTS SEGMENT GROWTH 95
10 LABORATORY FREEZERS MARKET, BY APPLICATION 96
10.1 INTRODUCTION 97
10.2 ENVIRONMENTAL TESTING 97
10.2.1 REFORMS IN ENVIRONMENTAL TESTING NORMS TO DRIVE DEMAND 97
10.3 GENETIC MATERIAL STORAGE 98
10.3.1 INCREASED RESEARCH INVESTMENTS IN OMICS RESEARCH TO DRIVE MARKET GROWTH 98
10.4 PHARMACEUTICAL & VACCINE STORAGE 99
10.4.1 TEMPERATURE-SENSITIVE REQUIREMENTS IN DRUG AND VACCINE MANUFACTURING TO DRIVE SEGMENT 99
10.5 BIOLOGICAL SAMPLES & INVENTORY MANAGEMENT 100
10.5.1 GROWTH IN SAMPLE VOLUME TO DRIVE DEMAND FOR REFRIGERATORS 100
10.6 OTHER APPLICATIONS 101
10.6.1 RAPID-RESPONSE COLD STORAGE DRIVING REPLACEMENT DEMAND ACROSS BLOOD BANKS AND TRANSFUSION SERVICES 101
11 LABORATORY FREEZERS MARKET, BY END USER 102
11.1 INTRODUCTION 103
11.2 HOSPITALS 104
11.2.1 RAPID-RESPONSE COLD STORAGE DRIVES REPLACEMENT DEMAND ACROSS EMERGENCY, ONCOLOGY, AND SURGICAL CARE 104
11.3 CLINICAL & PATHOLOGY LABORATORIES 104
11.3.1 DIGITAL PATHOLOGY AND AUTOMATION TO DRIVE MARKET GROWTH IN CLINICAL LABORATORIES 104
11.4 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 105
11.4.1 GMP-COMPLIANT ULTRA-LOW TEMPERATURE STORAGE SCALING TO DRIVE GROWTH 105
11.5 ACADEMIC & RESEARCH INSTITUTES 106
11.5.1 GREEN-LAB AND ENERGY-REDUCTION INITIATIVES RESHAPING FREEZER PROCUREMENT AND OPERATING PRACTICES 106
11.6 PHARMACIES & PHYSICIANS’ OFFICES 107
11.6.1 COMPLIANCE REQUIREMENTS FOR CHILDREN’S VACCINES TO BOOST SEGMENT 107
11.7 CELL & TISSUE BANKS 108
11.7.1 INCREASED ADOPTION OF FREEZERS IN MOLECULAR DIAGNOSTICS TO DRIVE MARKET EXPANSION 108
11.8 ENVIRONMENTAL LABS 109
11.8.1 INCREASED ADOPTION DUE TO STRICTER ENVIRONMENTAL MONITORING PROGRAMS 109
11.9 FORENSIC LABS 110
11.9.1 COLD-CASE RETESTING AND DNA EVIDENCE INTEGRITY REINFORCE LONG-TERM FROZEN STORAGE PROTOCOLS 110
11.10 FOOD & BEVERAGE COMPANIES 110
11.10.1 STRICT QUALITY CONTROL REQUIREMENTS TO DRIVE DEMAND 110
11.11 OTHER END USERS 111
11.11.1 LONG-TERM SAMPLE PRESERVATION TO DRIVE MARKET GROWTH IN OTHER END USERS 111
12 LABORATORY FREEZERS MARKET, BY REGION 112
12.1 INTRODUCTION 113
12.2 NORTH AMERICA 113
12.2.1 US 117
12.2.1.1 Established biopharma & R&D landscape to drive replacement cycle 117
12.2.2 CANADA 118
12.2.2.1 Growth in pharmaceutical R&D sector to grow demand for cold storage technologies 118
12.3 EUROPE 119
12.3.1 GERMANY 122
12.3.1.1 Strong local manufacturing footprints and established research infrastructure to drive market growth 122
12.3.2 UK 122
12.3.2.1 UKRI investments and national research infrastructure to fuel lab freezers adoption 122
12.3.3 FRANCE 123
12.3.3.1 Large research & development base to grow demand for cold storage samples 123
12.3.4 ITALY 124
12.3.4.1 Industry-academia partnership to drive market growth 124
12.3.5 SPAIN 124
12.3.5.1 Large clinical research base to drive freezer demand 124
12.3.6 REST OF EUROPE 125
12.4 ASIA PACIFIC 126
12.4.1 JAPAN 130
12.4.1.1 Increased investments in pharma manufacturing to drive market 130
12.4.2 CHINA 130
12.4.2.1 National GeneBank expansion and localized manufacturing scale to drive market growth 130
12.4.3 INDIA 131
12.4.3.1 National phenome and genome project to scale up demand for cold storage equipment 131
12.4.4 AUSTRALIA 132
12.4.4.1 Strong biobank network to drive demand cold storage options in Australia 132
12.4.5 SOUTH KOREA 132
12.4.5.1 Academic and medical institutes to drive demand for laboratory refrigeration solutions 132
12.4.6 REST OF ASIA PACIFIC 133
12.5 LATIN AMERICA 134
12.5.1 BRAZIL 137
12.5.1.1 Fiocruz biobank network and regional manufacturing base
– key drivers 137
12.5.2 MEXICO 137
12.5.2.1 Expansion in biopharmaceutical sector to boost market 137
12.5.3 REST OF LATIN AMERICA 138
12.6 MIDDLE EAST & AFRICA 139
12.6.1 GCC COUNTRIES 142
12.6.1.1 Government-led investments to grow market in GCC countries 142
12.6.2 REST OF MIDDLE EAST & AFRICA 142
13 COMPETITIVE LANDSCAPE 144
13.1 INTRODUCTION 144
13.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2023–2026 144
13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LABORATORY FREEZERS MARKET 144
13.3 REVENUE ANALYSIS, 2021–2025 146
13.4 MARKET SHARE ANALYSIS, 2025 146
13.4.1 MARKET RANKING OF KEY PLAYERS, 2025 148
13.5 COMPANY VALUATION AND FINANCIAL METRICS 148
13.5.1 FINANCIAL METRICS 148
13.5.2 COMPANY VALUATION 149
13.6 BRAND/PRODUCT COMPARISON 150
13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 151
13.7.1 STARS 151
13.7.2 EMERGING LEADERS 151
13.7.3 PERVASIVE PLAYERS 151
13.7.4 PARTICIPANTS 151
13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 153
13.7.5.1 Company footprint 153
13.7.5.2 Region footprint 153
13.7.5.3 Product footprint 154
13.7.5.4 Application footprint 155
13.7.5.5 End user footprint 155
13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 156
13.8.1 PROGRESSIVE COMPANIES 156
13.8.2 RESPONSIVE COMPANIES 156
13.8.3 DYNAMIC COMPANIES 156
13.8.4 STARTING BLOCKS 157
13.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 158
13.8.5.1 Detailed list of key startups/SMEs 158
13.8.5.2 Competitive benchmarking of key startups/SMEs 159
13.9 COMPETITIVE SCENARIO 161
13.9.1 PRODUCT LAUNCHES 161
13.9.2 DEALS 161
13.9.3 EXPANSIONS 162
14 COMPANY PROFILES 163
14.1 KEY PLAYERS 163
14.1.1 THERMO FISHER SCIENTIFIC INC. 163
14.1.1.1 Business overview 163
14.1.1.2 Products offered 164
14.1.1.3 Recent developments 165
14.1.1.3.1 Product launches 165
14.1.1.3.2 Expansions 166
14.1.1.4 MnM view 166
14.1.1.4.1 Right to win 166
14.1.1.4.2 Strategic choices 166
14.1.1.4.3 Weaknesses & competitive threats 166
14.1.2 HAIER BIOMEDICAL 167
14.1.2.1 Business overview 167
14.1.2.2 Products offered 168
14.1.2.3 Recent developments 169
14.1.2.3.1 Product launches 169
14.1.2.3.2 Deals 169
14.1.2.4 MnM view 170
14.1.2.4.1 Right to win 170
14.1.2.4.2 Strategic choices 170
14.1.2.4.3 Weaknesses & competitive threats 170
14.1.3 PHC HOLDINGS CORPORATION 171
14.1.3.1 Business overview 171
14.1.3.2 Products offered 172
14.1.3.3 Recent developments 173
14.1.3.3.1 Product launches 173
14.1.3.4 MnM view 174
14.1.3.4.1 Right to win 174
14.1.3.4.2 Strategic choices 174
14.1.3.4.3 Weaknesses & competitive threats 174
14.1.4 EPPENDORF SE 175
14.1.4.1 Business overview 175
14.1.4.2 Products offered 176
14.1.4.3 Recent developments 177
14.1.4.3.1 Product launches & approvals 177
14.1.4.3.2 Deals 177
14.1.4.3.3 Expansions 178
14.1.4.4 MnM view 178
14.1.4.4.1 Right to win 178
14.1.4.4.2 Strategic choices 178
14.1.4.4.3 Weaknesses & competitive threats 178
14.1.5 AVANTOR, INC. 179
14.1.5.1 Business overview 179
14.1.5.2 Products offered 180
14.1.5.3 Recent developments 181
14.1.5.3.1 Deals 181
14.1.6 HELMER SCIENTIFIC 182
14.1.6.1 Business overview 182
14.1.6.2 Products offered 182
14.1.6.3 Recent developments 183
14.1.6.3.1 Product launches & approvals 183
14.1.7 FOLLETT PRODUCTS, LLC 184
14.1.7.1 Business overview 184
14.1.7.2 Products offered 186
14.1.8 LIEBHERR 187
14.1.8.1 Business overview 187
14.1.8.2 Products offered 189
14.1.8.3 Recent developments 189
14.1.8.3.1 Product launches & approvals 189
14.1.9 FELIX STORCH, INC. 190
14.1.9.1 Business overview 190
14.1.9.2 Products offered 190
14.1.10 CUSTOM BIOGENIC SYSTEMS 191
14.1.10.1 Business overview 191
14.1.10.2 Products offered 191
14.1.11 BLUE STAR LIMITED 192
14.1.11.1 Business overview 192
14.1.11.2 Products offered 193
14.1.12 PHILIPP KIRSCH GMBH 194
14.1.12.1 Business overview 194
14.1.12.2 Products offered 194
14.2 OTHER PLAYERS 195
14.2.1 SO-LOW ENVIRONMENTAL EQUIPMENT CO. LTD 195
14.2.2 JEIO TECH 196
14.2.3 STERICOX INDIA PRIVATE LIMITED 197
14.2.4 THALHEIMER KÜHLUNG FEZO 198
14.2.5 B MEDICAL SYSTEMS 199
14.2.6 STANDEX INTERNATIONAL CORPORATION 200
14.2.7 EVERMED S.R.L 201
14.2.8 ARCTIKO 202
14.2.9 VESTFROST SOLUTIONS 203
14.2.10 KW TECNILABO 204
14.2.11 COLE PARMER 205
14.2.12 ZHONGKE MEILING CRYOGENICS COMPANY LIMITED 206
14.2.13 ESAW INDIA 207
15 RESEARCH METHODOLOGY 208
15.1 RESEARCH DATA 208
15.1.1 SECONDARY RESEARCH 209
15.1.1.1 Key secondary sources 211
15.1.1.2 Key data from secondary sources 211
15.1.2 PRIMARY RESEARCH 212
15.1.2.1 Key primary sources 212
15.1.2.2 Key supply- and demand-side participants 212
15.1.2.3 Breakdown of primary interviews 213
15.1.2.4 Key primary insights 214
15.2 MARKET SIZE ESTIMATION METHODOLOGY 214
15.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 215
15.2.2 END-USER-BASED MAPPING MARKET ESTIMATION 217
15.3 GROWTH FORECASTING MODEL 218
15.4 DATA TRIANGULATION AND MARKET BREAKDOWN 219
15.5 RESEARCH ASSUMPTIONS 220
15.6 RESEARCH LIMITATIONS 220
15.7 RISK ANALYSIS 221
16 APPENDIX 222
16.1 DISCUSSION GUIDE 222
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 226
16.3 CUSTOMIZATION OPTIONS 228
16.4 RELATED REPORTS 228
16.5 AUTHOR DETAILS 229
圖表清單 List of Tables & Figures
TABLE 1 LABORATORY FREEZERS MARKET: INCLUSIONS AND EXCLUSIONS OF STUDY 25
TABLE 2 IMPACT OF PORTER’S FIVE FORCES ON LABORATORY FREEZERS MARKET 41
TABLE 3 AVERAGE SELLING PRICE OF LABORATORY FREEZERS, BY REGION,
2023–2025 (USD) 50
TABLE 4 IMPORT DATA FOR FREEZERS OF THE UPRIGHT TYPE (HS CODE 841840),
BY COUNTRY, 2021–2025 (USD MILLION) 52
TABLE 5 EXPORT DATA FOR FREEZERS OF THE UPRIGHT TYPE (HS CODE 841840),
BY COUNTRY, 2021–2025 (USD MILLION) 53
TABLE 6 LABORATORY FREEZERS MARKET: KEY CONFERENCES AND EVENTS, 2026–2027 53
TABLE 7 CASE STUDY 1: REMOTE MONITORING IMPROVES ULT FREEZER FLEET MANAGEMENT 57
TABLE 8 CASE STUDY 2: PHCBI’S −86°C ULT FREEZER SUPPORTS LONG-TERM SAMPLE STORAGE FOR SEPSIS RESEARCH 57
TABLE 9 US ADJUSTED RECIPROCAL TARIFF RATES 58
TABLE 10 LABORATORY FREEZERS MARKET: KEY PATENT REGISTRATIONS, 2025-2026 63
TABLE 11 CASE STUDY 1: AI-BASED THERMAL MODELING FOR ULTRA-LOW-TEMPERATURE FREEZERS 65
TABLE 12 CASE STUDY 2: AI- AND CLOUD-ENABLED MONITORING FOR ULT FREEZERS 65
TABLE 13 INTERCONNECTED ADJACENT ECOSYSTEMS AND IMPACT ON MARKET PLAYERS 66
TABLE 14 MEDICAL DEVICE CLASSIFICATION BY US FDA 68
TABLE 15 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 69
TABLE 16 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 69
TABLE 17 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY 71
TABLE 18 CHINA: CLASSIFICATION OF MEDICAL DEVICES 72
TABLE 19 NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 20 EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
TABLE 21 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 75
TABLE 22 LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
TABLE 23 MIDDLE EAST & AFRICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 76
TABLE 24 INDUSTRY STANDARDS FOR LABORATORY FREEZERS MARKET 77
TABLE 25 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS IN LABORATORY FREEZERS MARKET, BY PRODUCT (%) 79
TABLE 26 KEY BUYING CRITERIA FOR LABORATORY FREEZER PRODUCTS 80
TABLE 27 LABORATORY FREEZERS MARKET, BY PRODUCT, 2024–2031 (USD MILLION) 84
TABLE 28 FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 85
TABLE 29 FREEZERS MARKET, BY REGION, 2024–2031 (USD MILLION) 85
TABLE 30 ULTRA-LOW-TEMPERATURE FREEZERS MARKET, BY REGION,
2024–2031 (USD MILLION) 86
TABLE 31 GENERAL-PURPOSE FREEZERS MARKET, BY REGION, 2024–2031 (USD MILLION) 87
TABLE 32 PLASMA FREEZERS MARKET, BY REGION, 2024–2031 (USD MILLION) 87
TABLE 33 ENZYME FREEZERS MARKET, BY REGION, 2024–2031 (USD MILLION) 88
TABLE 34 EXPLOSION-PROOF FREEZERS MARKET, BY REGION, 2024–2031 (USD MILLION) 89
TABLE 35 FLAMMABLE MATERIAL FREEZERS MARKET, BY REGION,
2024–2031 (USD MILLION) 89
TABLE 36 REFRIGERATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 90
TABLE 37 REFRIGERATORS MARKET, BY REGION, 2024–2031 (USD MILLION) 90
TABLE 38 BLOOD BANK REFRIGERATORS MARKET, BY REGION, 2024–2031 (USD MILLION) 91
TABLE 39 CHROMATOGRAPHY REFRIGERATORS MARKET, BY REGION,
2024–2031 (USD MILLION) 92
TABLE 40 EXPLOSION-PROOF REFRIGERATORS MARKET, BY REGION,
2024–2031 (USD MILLION) 92
TABLE 41 FLAMMABLE MATERIAL REFRIGERATORS MARKET, BY REGION,
2024–2031 (USD MILLION) 93
TABLE 42 LABORATORY REFRIGERATORS MARKET, BY REGION, 2024–2031 (USD MILLION) 94
TABLE 43 PHARMACY REFRIGERATORS MARKET, BY REGION, 2024–2031 (USD MILLION) 94
TABLE 44 CRYOPRESERVATION SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 95
TABLE 45 LABORATORY FREEZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 97
TABLE 46 LABORATORY FREEZERS MARKET FOR ENVIRONMENTAL TESTING, BY REGION, 2024–2031 (USD MILLION) 98
TABLE 47 LABORATORY FREEZERS MARKET FOR GENETIC MATERIAL STORAGE, BY REGION, 2024–2031 (USD MILLION) 99
TABLE 48 LABORATORY FREEZERS MARKET FOR PHARMACEUTICAL & VACCINE STORAGE,
BY REGION, 2024–2031 (USD MILLION) 100
TABLE 49 LABORATORY FREEZERS MARKET FOR BIOLOGICAL SAMPLES & INVENTORY MANAGEMENT, BY REGION, 2024–2031 (USD MILLION) 100
TABLE 50 LABORATORY FREEZERS MARKET FOR OTHER APPLICATIONS, BY REGION,
2024–2031 (USD MILLION) 101
TABLE 51 LABORATORY FREEZERS MARKET, BY END USER, 2024–2031 (USD MILLION) 103
TABLE 52 LABORATORY FREEZERS MARKET FOR HOSPITALS, BY REGION,
2024–2031 (USD MILLION) 104
TABLE 53 LABORATORY FREEZERS MARKET FOR CLINICAL & PATHOLOGY LABORATORIES,
BY REGION, 2024–2031 (USD MILLION) 105
TABLE 54 LABORATORY FREEZERS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 106
TABLE 55 LABORATORY FREEZERS MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY REGION, 2024–2031 (USD MILLION) 107
TABLE 56 LABORATORY FREEZERS MARKET FOR PHARMACIES & PHYSICIANS’ OFFICES,
BY REGION, 2024–2031 (USD MILLION) 108
TABLE 57 LABORATORY FREEZERS MARKET FOR CELL & TISSUE BANKS, BY REGION,
2024–2031 (USD MILLION) 109
TABLE 58 LABORATORY FREEZERS MARKET FOR ENVIRONMENTAL LABS, BY REGION,
2024–2031 (USD MILLION) 109
TABLE 59 LABORATORY FREEZERS MARKET FOR FORENSIC LABS, BY REGION,
2024–2031 (USD MILLION) 110
TABLE 60 LABORATORY FREEZERS MARKET FOR FOOD & BEVERAGE COMPANIES,
BY REGION, 2024–2031 (USD MILLION) 111
TABLE 61 LABORATORY FREEZERS MARKET FOR OTHER END USERS, BY REGION,
2024–2031 (USD MILLION) 111
TABLE 62 LABORATORY FREEZERS MARKET, BY REGION, 2024–2031 (USD MILLION) 113
TABLE 63 NORTH AMERICA: LABORATORY FREEZERS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 114
TABLE 64 NORTH AMERICA: LABORATORY FREEZERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 115
TABLE 65 NORTH AMERICA: FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 115
TABLE 66 NORTH AMERICA: REFRIGERATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 116
TABLE 67 NORTH AMERICA: LABORATORY FREEZERS MARKET, BY END USER,
2024–2031 (USD MILLION) 116
TABLE 68 NORTH AMERICA: LABORATORY FREEZERS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 117
TABLE 69 US: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 118
TABLE 70 CANADA: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 118
TABLE 71 EUROPE: LABORATORY FREEZERS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 119
TABLE 72 EUROPE: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 119
TABLE 73 EUROPE: FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 120
TABLE 74 EUROPE: REFRIGERATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 120
TABLE 75 EUROPE: LABORATORY FREEZERS MARKET, BY END USER,
2024–2031 (USD MILLION) 121
TABLE 76 EUROPE: LABORATORY FREEZERS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 121
TABLE 77 GERMANY: LABORATORY FREEZERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 122
TABLE 78 UK: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 123
TABLE 79 FRANCE: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 123
TABLE 80 ITALY: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 124
TABLE 81 SPAIN: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 125
TABLE 82 REST OF EUROPE: LABORATORY FREEZERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 125
TABLE 83 ASIA PACIFIC: LABORATORY FREEZERS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 127
TABLE 84 ASIA PACIFIC: LABORATORY FREEZERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 127
TABLE 85 ASIA PACIFIC: FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 128
TABLE 86 ASIA PACIFIC: REFRIGERATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 128
TABLE 87 ASIA PACIFIC: LABORATORY FREEZERS MARKET, BY END USER,
2024–2031 (USD MILLION) 129
TABLE 88 ASIA PACIFIC: LABORATORY FREEZERS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 129
TABLE 89 JAPAN: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 130
TABLE 90 CHINA: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 131
TABLE 91 INDIA: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 131
TABLE 92 AUSTRALIA: LABORATORY FREEZERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 132
TABLE 93 SOUTH KOREA: LABORATORY FREEZERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 133
TABLE 94 REST OF ASIA PACIFIC: LABORATORY FREEZERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 133
TABLE 95 LATIN AMERICA: LABORATORY FREEZERS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 134
TABLE 96 LATIN AMERICA: LABORATORY FREEZERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 134
TABLE 97 LATIN AMERICA: FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 135
TABLE 98 LATIN AMERICA: REFRIGERATORS MARKET, BY TYPE, 2024–2031 (USD MILLION) 135
TABLE 99 LATIN AMERICA: LABORATORY FREEZERS MARKET, BY END USER,
2024–2031 (USD MILLION) 136
TABLE 100 LATIN AMERICA: LABORATORY FREEZERS MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 136
TABLE 101 BRAZIL: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 137
TABLE 102 MEXICO: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 138
TABLE 103 REST OF LATIN AMERICA: LABORATORY FREEZERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 138
TABLE 104 MIDDLE EAST & AFRICA: LABORATORY FREEZERS MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 139
TABLE 105 MIDDLE EAST & AFRICA: LABORATORY FREEZERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 139
TABLE 106 MIDDLE EAST & AFRICA: FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 140
TABLE 107 MIDDLE EAST & AFRICA: REFRIGERATORS MARKET, BY TYPE,
2024–2031 (USD MILLION) 140
TABLE 108 MIDDLE EAST & AFRICA: LABORATORY FREEZERS MARKET, BY END USER,
2024–2031 (USD MILLION) 141
TABLE 109 MIDDLE EAST & AFRICA: LABORATORY FREEZERS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 141
TABLE 110 GCC COUNTRIES: LABORATORY FREEZERS MARKET, BY TYPE,
2024–2031 (USD MILLION) 142
TABLE 111 REST OF MIDDLE EAST & AFRICA: LABORATORY FREEZERS MARKET, BY TYPE, 2024–2031 (USD MILLION) 143
TABLE 112 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN LABORATORY FREEZERS MARKET, 2023–2026 144
TABLE 113 LABORATORY FREEZERS MARKET: DEGREE OF COMPETITION 147
TABLE 114 LABORATORY FREEZERS MARKET: REGION FOOTPRINT 153
TABLE 115 LABORATORY FREEZERS MARKET: PRODUCT FOOTPRINT 154
TABLE 116 LABORATORY FREEZERS MARKET: APPLICATION FOOTPRINT 155
TABLE 117 LABORATORY FREEZERS MARKET: END USER FOOTPRINT 155
TABLE 118 LABORATORY FREEZERS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 158
TABLE 119 LABORATORY FREEZERS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY PRODUCT 159
TABLE 120 LABORATORY FREEZERS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY REGION 160
TABLE 121 LABORATORY FREEZERS MARKET: PRODUCT LAUNCHES,
JANUARY 2023–JUNE 2026 161
TABLE 122 LABORATORY FREEZERS MARKET: DEALS, JANUARY 2023–JUNE 2026 161
TABLE 123 LABORATORY FREEZERS MARKET: EXPANSIONS, JANUARY 2023–JUNE 2026 162
TABLE 124 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 163
TABLE 125 THERMO FISHER SCIENTIFIC INC: PRODUCTS OFFERED 164
TABLE 126 THERMO FISHER SCIENTIFIC, INC: PRODUCT LAUNCHES,
JANUARY 2023–JUNE 2026 165
TABLE 127 THERMO FISHER SCIENTIFIC, INC: EXPANSIONS, JANUARY 2023–JUNE 2026 166
TABLE 128 HAIER BIOMEDICAL: COMPANY OVERVIEW 167
TABLE 129 HAIER BIOMEDICAL: PRODUCTS OFFERED 168
TABLE 130 HAIER BIOMEDICAL: PRODUCT LAUNCHES, JANUARY 2023–JUNE 2026 169
TABLE 131 HAIER BIOMEDICAL: DEALS, JANUARY 2023–JUNE 2026 169
TABLE 132 PHC HOLDINGS CORPORATION: BUSINESS OVERVIEW 171
TABLE 133 PHC HOLDINGS CORPORATION: PRODUCTS OFFERED 172
TABLE 134 PHC HOLDINGS CORPORATION: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2023–JUNE 2026 173
TABLE 135 EPPENDORF SE: COMPANY OVERVIEW 175
TABLE 136 EPPENDORF SE: PRODUCTS OFFERED 176
TABLE 137 EPPENDORF SE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JUNE 2026 177
TABLE 138 EPPENDORF SE: DEALS, JANUARY 2023–JUNE 2026 177
TABLE 139 EPPENDORF SE: EXPANSIONS, JANUARY 2023–JUNE 2026 178
TABLE 140 AVANTOR, INC.: COMPANY OVERVIEW 179
TABLE 141 AVANTOR, INC.: PRODUCTS OFFERED 180
TABLE 142 AVANTOR, INC.: DEALS, JANUARY 2023–JUNE 2026 181
TABLE 143 HELMER SCIENTIFIC: COMPANY OVERVIEW 182
TABLE 144 HELMER SCIENTIFIC: PRODUCTS OFFERED 182
TABLE 145 HELMER SCIENTIFIC: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2023–JUNE 2026 183
TABLE 146 FOLLETT SCIENTIFIC: COMPANY OVERVIEW 184
TABLE 147 FOLLETT SCIENTIFIC: PRODUCTS OFFERED 186
TABLE 148 LIEBHERR: COMPANY OVERVIEW 187
TABLE 149 LIEBHERR: PRODUCTS OFFERED 189
TABLE 150 LIEBHERR : PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–JUNE 2026 189
TABLE 151 FELIX STORCH, INC.: COMPANY OVERVIEW 190
TABLE 152 FELIX STORCH, INC.: PRODUCTS OFFERED 190
TABLE 153 CUSTOM BIOGENIC SYSTEMS: COMPANY OVERVIEW 191
TABLE 154 CUSTOM BIOGENIC SYSTEMS : PRODUCTS OFFERED 191
TABLE 155 BLUE STAR LIMITED: COMPANY OVERVIEW 192
TABLE 156 BLUE STAR LIMITED: PRODUCTS OFFERED 193
TABLE 157 PHILIPP KIRSCH GMBH : COMPANY OVERVIEW 194
TABLE 158 PHILIPP KIRSCH GMBH : PRODUCTS OFFERED 194
TABLE 159 SO-LOW ENVIRONMENTAL EQUIPMENT CO. LTD: COMPANY OVERVIEW 195
TABLE 160 JEIO TECH: COMPANY OVERVIEW 196
TABLE 161 STERICOX INDIA PRIVATE LIMITED: COMPANY OVERVIEW 197
TABLE 162 THALHEIMER KÜHLUNG FEZO: COMPANY OVERVIEW 198
TABLE 163 B MEDICAL SYSTEMS : COMPANY OVERVIEW 199
TABLE 164 STANDEX INTERNATIONAL CORPORATION: COMPANY OVERVIEW 200
TABLE 165 EVERMED S.R.L: COMPANY OVERVIEW 201
TABLE 166 ARCTIKO: COMPANY OVERVIEW 202
TABLE 167 VESTFROST SOLUTIONS: COMPANY OVERVIEW 203
TABLE 168 KW TECNILABO: COMPANY OVERVIEW 204
TABLE 169 COLE PARMER: COMPANY OVERVIEW 205
TABLE 170 ZHONGKE MEILING CRYOGENICS COMPANY LIMITED: COMPANY OVERVIEW 206
TABLE 171 ESAW INDIA: COMPANY OVERVIEW 207
TABLE 172 LABORATORY FREEZERS MARKET: RISK ANALYSIS 221
FIGURE 1 LABORATORY FREEZERS MARKET SEGMENTATION AND REGIONAL SCOPE 24
FIGURE 2 LABORATORY FREEZERS MARKET: YEARS CONSIDERED 25
FIGURE 3 MARKET SCENARIO 27
FIGURE 4 GLOBAL LABORATORY FREEZERS MARKET, 2024–2031 27
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN LABORATORY FREEZERS MARKET, 2023–2025 28
FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF LABORATORY FREEZERS MARKET 29
FIGURE 7 HIGH-GROWTH SEGMENTS IN LABORATORY FREEZERS MARKET, 2026–2031 30
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN LABORATORY FREEZERS MARKET DURING FORECAST PERIOD 31
FIGURE 9 EXPANSION OF BIOPHARMACEUTICAL RESEARCH AND COLD-STORAGE REQUIREMENTS TO DRIVE MARKET 32
FIGURE 10 US AND FREEZERS ACCOUNTED FOR LARGEST SHARE IN NORTH AMERICA
IN 2025 33
FIGURE 11 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 34
FIGURE 12 LABORATORY FREEZERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 36
FIGURE 13 IMPACT OF PORTER’S FIVE FORCES ON LABORATORY FREEZERS MARKET 41
FIGURE 14 LABORATORY FREEZERS MARKET: SUPPLY CHAIN ANALYSIS 44
FIGURE 15 LABORATORY FREEZERS MARKET: VALUE CHAIN ANALYSIS 46
FIGURE 16 LABORATORY FREEZERS MARKET: ECOSYSTEM ANALYSIS 47
FIGURE 17 AVERAGE SELLING PRICE OF LABORATORY FREEZERS, BY REGION,
2025 (USD THOUSAND) 50
FIGURE 18 IMPORT SCENARIO FOR HS CODE 841840, 2021–2025 (USD MILLION) 51
FIGURE 19 EXPORT SCENARIO FOR HS CODE 841840, 2021–2025 (USD MILLION) 52
FIGURE 20 LABORATORY FREEZERS MARKET: TRENDS/DISRUPTIONS IMPACTING
CUSTOMER BUSINESS 55
FIGURE 21 FUNDING SCENARIO AND NUMBER OF DEALS IN LABORATORY FREEZERS MARKET, 2019–2023 55
FIGURE 22 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 56
FIGURE 23 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION) 56
FIGURE 24 LABORATORY FREEZERS MARKET: PATENT ANALYSIS, 2015–2025 62
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT 79
FIGURE 26 KEY BUYING CRITERIA FOR LABORATORY FREEZER PRODUCTS 80
FIGURE 27 NORTH AMERICA: LABORATORY FREEZERS MARKET SNAPSHOT 114
FIGURE 28 ASIA PACIFIC: LABORATORY FREEZERS MARKET SNAPSHOT 126
FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN LABORATORY FREEZERS MARKET,
2021–2025 (USD MILLION) 146
FIGURE 30 SHARE ANALYSIS OF KEY PLAYERS IN LABORATORY FREEZERS MARKET, 2025 146
FIGURE 31 RANKING OF KEY PLAYERS IN LABORATORY FREEZERS MARKET, 2025 148
FIGURE 32 EV/EBITDA OF TOP KEY PLAYERS (2026) 148
FIGURE 33 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF TOP THREE PLAYERS (2026) 149
FIGURE 34 LABORATORY FREEZERS: BRAND/PRODUCT COMPARATIVE ANALYSIS 150
FIGURE 35 LABORATORY FREEZERS MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2025 152
FIGURE 36 LABORATORY FREEZERS MARKET: COMPANY FOOTPRINT 153
FIGURE 37 LABORATORY FREEZERS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 157
FIGURE 38 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025) 164
FIGURE 39 HAIER BIOMEDICAL: COMPANY SNAPSHOT (2025) 167
FIGURE 40 PHC HOLDINGS CORPORATION: COMPANY SNAPSHOT (2025) 172
FIGURE 41 EPPENDORF SE: COMPANY SNAPSHOT (2025) 176
FIGURE 42 AVANTOR, INC.: COMPANY SNAPSHOT (2025) 180
FIGURE 43 FOLLETT PRODUCTS, LLC: COMPANY SNAPSHOT (2025) 185
FIGURE 44 LIEBHERR: COMPANY SNAPSHOT (2025) 188
FIGURE 45 BLUE STAR LIMITED: COMPANY SNAPSHOT (2025) 193
FIGURE 46 LABORATORY FREEZERS MARKET: RESEARCH DATA 208
FIGURE 47 LABORATORY FREEZERS MARKET: RESEARCH DESIGN 209
FIGURE 48 LABORATORY FREEZERS MARKET: KEY SECONDARY SOURCES 211
FIGURE 49 LABORATORY FREEZERS MARKET: KEY DATA FROM SECONDARY SOURCES 211
FIGURE 50 LABORATORY FREEZERS MARKET: KEY PRIMARY SOURCES
(DEMAND AND SUPPLY SIDES) 212
FIGURE 51 LABORATORY FREEZERS MARKET: KEY SUPPLY- AND DEMAND-SIDE PARTICIPANTS 212
FIGURE 52 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 213
FIGURE 53 LABORATORY FREEZERS MARKET: KEY INSIGHTS FROM PRIMARY EXPERTS 214
FIGURE 54 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 215
FIGURE 55 LABORATORY FREEZERS MARKET: COMPANY REVENUE ESTIMATION, 2025 216
FIGURE 56 LABORATORY FREEZERS MARKET: MARKET SIZE ESTIMATION METHODOLOGY 217
FIGURE 57 LABORATORY FREEZERS MARKET: GROWTH PROJECTIONS BASED ON REVENUE IMPACT OF KEY MACRO INDICATORS 218
FIGURE 58 DATA TRIANGULATION 219
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們